Detalhe da pesquisa
1.
Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine.
Nature
; 597(7875): 268-273, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34320609
2.
Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia.
Acta Haematol
; : 1-8, 2023 Oct 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37848002
3.
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.
Cancer Immunol Immunother
; 71(2): 251-265, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34125345
4.
Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice.
Br J Cancer
; 124(8): 1346-1352, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33589773
5.
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer.
Breast Cancer Res Treat
; 188(2): 369-377, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34125340
6.
Tspan8 is expressed in breast cancer and regulates E-cadherin/catenin signalling and metastasis accompanied by increased circulating extracellular vesicles.
J Pathol
; 248(4): 421-437, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30982971
7.
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
Acta Haematol
; 143(3): 217-231, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-31590170
8.
Biosimilars in oncology: key role of nurses in patient education.
Future Oncol
; 16(25): 1931-1939, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32618476
9.
Complete remission of Cdx-2 positive primary testicular carcinoid tumor: 10-years follow-up and literature review.
BMC Urol
; 20(1): 197, 2020 Dec 14.
Artigo
Inglês
| MEDLINE | ID: mdl-33317491
10.
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
Haematologica
; 104(5): 955-962, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30514803
11.
Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia.
Ann Hematol
; 98(5): 1217-1224, 2019 May.
Artigo
Inglês
| MEDLINE | ID: mdl-30824956
12.
Imatinib Mesylate.
Recent Results Cancer Res
; 212: 1-27, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30069623
13.
Afatinib.
Recent Results Cancer Res
; 211: 199-215, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30069769
14.
Gefitinib.
Recent Results Cancer Res
; 211: 235-246, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30069771
15.
Alectinib.
Recent Results Cancer Res
; 211: 247-256, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30069772
16.
A pharmacokinetics phase 1 bioequivalence study of the trastuzumab biosimilar MYL-1401O vs. EU-trastuzumab and US-trastuzumab.
Br J Clin Pharmacol
; 84(10): 2336-2343, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29926514
17.
Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.
JAMA
; 317(1): 37-47, 2017 01 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27918780
18.
Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial.
Haematologica
; 101(9): 1065-73, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27247324
19.
High Rates of Thromboembolic Events in Patients with Germ Cell Cancer Undergoing Cisplatin-Based Polychemotherapy.
Urol Int
; 96(4): 399-405, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27074038
20.
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.
Ann Hematol
; 94(12): 2015-24, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26385387